The emerging roles of human tissue kallikreins in cancer

被引:524
作者
Borgoño, CA [1 ]
Diamandis, EP [1 ]
机构
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1038/nrc1474
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. Although primarily known for their clinical applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis. They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.
引用
收藏
页码:876 / 890
页数:15
相关论文
共 198 条
[21]   The tissue kallikrein family of serine proteases: Functional roles in human disease and potential as clinical [J].
Clements, JA ;
Willemsen, NM ;
Myers, SA ;
Dong, Y .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (03) :265-312
[22]   Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter [J].
Cleutjens, KBJM ;
vanEekelen, CCEM ;
vanderKorput, HAGM ;
Brinkmann, AO ;
Trapman, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6379-6388
[23]   Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates [J].
Cloutier, SM ;
Kündig, C ;
Felber, LM ;
Fattah, OM ;
Chagas, JR ;
Gygi, CM ;
Jichlinski, P ;
Leisinger, HJ ;
Deperthes, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (03) :607-613
[24]   Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology [J].
Cloutier, SM ;
Chagas, JR ;
Mach, JP ;
Gygi, CM ;
Leisinger, HJ ;
Deperthes, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (11) :2747-2754
[25]   PROSTATE-SPECIFIC ANTIGEN (PSA) IS AN INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 PROTEASE FOUND IN SEMINAL PLASMA [J].
COHEN, P ;
GRAVES, HCB ;
PEEHL, DM ;
KAMAREI, M ;
GIUDICE, LC ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04) :1046-1053
[26]   Substrate specificity of prostate-specific antigen (PSA) [J].
Coombs, GS ;
Bergstrom, RC ;
Pellequer, JL ;
Baker, SI ;
Navre, M ;
Smith, MM ;
Tainer, JA ;
Madison, EL ;
Corey, DR .
CHEMISTRY & BIOLOGY, 1998, 5 (09) :475-488
[27]   Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels [J].
Cramer, SD ;
Chang, BL ;
Rao, A ;
Hawkins, GA ;
Zheng, SL ;
Wade, WN ;
Cooke, RT ;
Thomas, LN ;
Bleecker, ER ;
Catalona, WJ ;
Sterling, DA ;
Meyers, DA ;
Ohar, J ;
Xu, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14) :1044-1053
[28]   Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts [J].
Cramer, SD ;
Chen, ZX ;
Peehl, DM .
JOURNAL OF UROLOGY, 1996, 156 (02) :526-531
[29]   Differential expression of protease-activated receptors-1 and-2 in stromal fibroblasts of normal, benign, and malignant human tissues [J].
D'Andrea, MR ;
Derian, CK ;
Santulli, RJ ;
Andrade-Gordon, P .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :2031-2041
[30]   Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker [J].
Darson, MF ;
Pacelli, A ;
Roche, P ;
Rittenhouse, HG ;
Wolfert, RL ;
Young, CYF ;
Klee, GG ;
Tindall, DJ ;
Bostwick, DG .
UROLOGY, 1997, 49 (06) :857-862